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Asthma affects nearly 14 million people worldwide and has been steadily increasing in frequency for the past 50
years. Although environmental factors clearly influence the onset, progression, and severity of this disease, family
and twin studies indicate that genetic variation also influences susceptibility. Linkage of asthma and related phe-
notypes to chromosome 6p21 has been reported in seven genome screens, making it the most replicated region of
the genome. However, because many genes with individually small effects are likely to contribute to risk, identi-
fication of asthma susceptibility loci has been challenging. In this study, we present evidence from four independent
samples in support of HLA-G as a novel asthma and bronchial hyperresponsiveness susceptibility gene in the human
leukocyte antigen region on chromosome 6p21, and we speculate that this gene might contribute to risk for other
inflammatory diseases that show linkage to this region.
We conducted a genomewide screen of families who par-
ticipated in the Collaborative Study on the Genetics of
Asthma (CSGA) (Collaborative Study on the Genetics of
Asthma 1997; Xu et al. 2001). The strongest linkage sig-
nal in 129 white families was on chromosome 6p21 at
marker D6S1281 ( ; ), which is 2.5LODp 1.91 Pp .003
cM telomeric to the human leukocyte antigen (HLA) com-
plex. All the evidence of linkage to asthma was found in
the 35 white families ascertained in Chicago (LODp
) (fig. 1A). We focused our subsequent studies on these3.6
families, as well as on 46 white child-parent trios with
asthma (MIM 600807) also ascertained in Chicago and
two other populations that had previously shown evi-
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dence of linkage of asthma-associated phenotypes to
markers in this region (table 1) (Ober et al. 2000; Kop-
pelman et al. 2002). Details of the statistical methods are
described in appendix A (online only).
To further narrow the linked region, we genotyped
the Chicago families for five additional STRPs—two that
reside within the HLA region (DQ.CAR and TNFa) and
three flanking markers (D6S258, MOGc, and D6S1680)
(fig. 1A). The LOD score increased to 3.8, peaking at
MOGc. The information content (Nicolae and Kong
2004) in this region was 95%, indicating that we could
not increase the LOD score or improve the resolution
by adding more markers. Furthermore, the MOGc 136-
bp allele was overtransmitted to asthmatic children in
the families (42 transmissions [TR]:23 nontransmissions
[NT]; P [corrected for relatedness and number of alleles]
p .06). In the trios, the MOGc 134-bp allele was ov-
ertransmitted to asthmatic children (17 TR:6 NT). Be-
cause of the extensive linkage disequilibrium (LD) in the
HLA region (Begovich et al. 1992), the disease locus
could have been located at a far distance, despite the evi-
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Figure 1 Linkage to 6p21 in the Chicago families. A, The dashed line shows the results of the initial genome screen with framework
markers. The solid line shows the results of five additional STRPs between framework markers D6S1281 and D6S1019. B, 1-Mb region from
D6S258 to D6S265 with positional candidate genes. (All known genes [blue]—but not all pseudogenes [brown], STRPs [green], and intragenic
SNPs [purple]—are included.) Circles p SNPs; triangles p in/dels; squares p STRPs; rectangle p HLA-A genotype, which is comprised of
multiple SNPs. See appendix A (online only) for allele frequencies and results of association studies.
dence of association between MOGc alleles and asthma
in two independent samples. To determine whether the
haplotype shared among affected individuals extended
into the HLA region, we genotyped the families at the
HLA-A gene and at six STRPs spanning the HLA class
I region between TNFa and HLA-A. There was no ev-
idence of association with HLA-A or with markers prox-
imal to it (data not shown).
Chromosome 6p21 is one of the best characterized
regions in the human genome, and the nucleotide se-
quence between D6S258 and D6S265 is known (Mungall
et al. 2003; Stewart et al. 2004). This region is gene rich,
with 20 known or predicted genes and at least 30 pseu-
dogenes in the 1-Mb region from HLA-A to OR2B3 (fig.
1B). To localize the susceptibility-associated variation, we
genotyped the Chicago families and trios for an additional
59 polymorphisms in 19 genes, two pseudogenes, and the
intergenic regions flanking the HLA-A and HLA-G loci
(fig. 1B; tables A1 and A4 [online only]). Our strategy
was to genotype one common SNP every 10–20 kb across
each gene between D6S258 and D6S265, as well as all
nonsynonomous SNPs, when possible. SNPs were selected
from dbSNP or were discovered in our laboratory. We
previously extensively characterized the haplotype struc-
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Table 1













Sex (% male) 59.4 60.6 53.2 62.0 42.3
Asthma (%) 100 100 48.0 100 40.7
BHR (%) 100 100 100 100 100
Mean % predicted FEV1 (SD) 88.64 (17.12) 80.13 (16.83) 95.58 (15.71) 69.62 (24.68) 89.49 (12.10)
Mean FEV1/FVC (SD) .82 (.09) .77 (.10) .79 (.10) .597f (.149) .80f (.086)
Mean log IgE (SD) IU 2.11 (.73) 2.19 (.71) 1.60 (.77) 1.95 (.69) 1.95 (.76)
Atopyg (%) 67.2 79.8 51.0 81.9 59.1
NOTE.—These studies were approved by the institutional review boards at each institution. Not all individuals were genotyped at
all marker loci.
a CSGA families were ascertained through two siblings with asthma and were extended to include other affected relatives, never
skipping more than one unaffected relative (Lester et al. 2001). Asthma was diagnosed as follows: (1) either a fall in baseline FEV1
by 20% at 25 mg/ml methacholine (BHR) or an increase of 15% in baseline FEV1 after bronchodilator use; (2) two of the
following symptoms: cough, wheeze, or shortness of breath (dyspnea); and (3) current medication use or doctor’s diagnosis of asthma.
All participating relatives of the siblings were studied.
b Family size ranged from 4 to 18 members (mean family size, 7 members).
c Trios were individuals meeting the same criteria as the CSGA patients with asthma and their parents, who were not evaluated
( ).np 46
d Hutterites ( ), who are related to each other in a 13-generation, 1,623-member pedigree, were evaluated using a modifiednp 693
CSGA protocol (Ober et al. 2000). BHR in this group was defined as a fall in baseline FEV1 by 20% at 25 mg/ml methacholine.
e The 200 Dutch families were recruited ∼30 years ago through a proband who was diagnosed as having asthma; they were
reevaluated in the 1990s, along with their spouses, children, and grandchildren (Panhuysen et al. 1995). The families included 1,183
individuals. BHR in this group was defined as a fall in baseline FEV1 by 20% at 32 mg/ml histamine (30′ protocol).
f FEV1/VC.
g Defined as a positive skin-prick test to airborne allergens.
ture of the HLA-G gene (MIM 142871) in the Hutterites
(Ober et al. 1996, 2003). In this gene, we selected SNPs
that identify clusters of variants either that are in perfect
or near-perfect LD or that uniquely define all of the com-
mon HLA-G alleles, as in our previous study (Ober et al.
2003). SNPs in intergenic regions were selected to char-
acterize the LD pattern in the proximal end of the region.
To investigate whether any of these variants explained
some or all of the original evidence of linkage in the fam-
ilies, we conditioned on the genotype at each polymorphic
site and reexamined the evidence of linkage. Multipoint
analysis conditional on the genotypes of one variant in
the HLA-G gene (1489C/T, His93His) yielded a LOD
score of 0.9, which is substantially lower than the max-
imum LOD score (3.8) in this region. Analyses conditional
on the other variants led to LOD scores 10.9. Thus, var-
iation in the HLA-G gene accounted for most of the link-
age in the families; the remaining evidence of linkage
could be due to chance sharing among affected family
members (Sun et al. 2002) or to the presence of a second
susceptibility locus in the linked region. Nonetheless, it is
notable that conditioning on a single SNP could result in
a reduction in the LOD score of this magnitude (Sun et
al. 2002).
We next examined the pattern of LD across this region
in unrelated individuals from the Chicago families and
trios and identified five LD blocks (Zhang et al. 2002a)
(fig. 2A). To determine which LD block contains variation
that contributes to asthma susceptibility, we examined
pairwise combinations of SNPs within each block by the
transmission/disequilibrium test (TDT), conditional on
the evidence of linkage at each position. Only pairwise
combinations of SNPs in block 2 showed significant non-
random transmission of haplotypes ( ) in both theP ! .001
families and the trios (fig. 2B; table A2 [online only]).
Analyses of the individual variants revealed that poly-
morphisms in HLA-G (block 2) were associated with
asthma in both the families and the trios; SNPs in two
genes in block 4 (OR12D2 and OR10C1) and one gene
each in block 3 (GABBR1) and block 5 (OR5V) were
associated with asthma in the families only (table A3
[online only]). Thus, the HLA-G gene in block 2 was
the only gene that showed evidence of association with
asthma in both the families and the trios. However, in
the families, the association was with a haplotype carrying
the964G allele (43 TR:25 NT), whereas the association
in the trios was with a haplotype carrying the 964A
allele (23 TR:12 NT).
To further localize and characterize the susceptibility
locus, we genotyped selected markers in two populations
that previously showed linkage of asthma-related phe-
notypes to 6p21: (1) the Hutterites, a founder population
of European descent, and (2) Dutch families (Ober et al.
2000; Koppelman et al. 2002). Because of the different
Figure 2 LD block structure in the extended class I region. A, Graph of LD map, showing LDUs on the Y-axis and distance on the X-
axis (Zhang et al. 2002a). Shaded boxes show the five blocks in this region. B, Pairwise TDT of variants within each block. Results for Chicago
families are shown in the lower half, and results for Chicago trios are in the upper half. P values were derived by simulations that were
conditioned on the evidence of linkage but were not corrected for multiple comparisons.
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Table 2
Number of Dutch Children with BHR and Atopy, by Child’s





WITH AFFECTED STATUS OF
BHR BHR Atopy Atopy
AA:
BHR 22 28 33 18
BHR 27 30 32 25
AG:
BHR 57 63 62 59
BHR 56 68 60 67
GG:
BHR 57 45 44 61
BHR 18 50 28 44
NOTE.—The prevalence of BHR in children is influenced by
both the child’s genotype and the mother’s affection status.
Among GG children, the prevalence of BHR is 56% if the mother
has BHR and 26% if the mother does not have BHR (Pp
). The prevalence of atopy in children is influenced by the.001
child’s genotype but not the mother’s affection status (Pp
for differences between genotypes)..006
ascertainment schemes, we used different approaches in
each sample. Ascertainment in the Hutterites was popu-
lation based; individuals in this single, large pedigree were
not selected on the basis of any particular phenotype. As
a result, we used a test of association that was designed
for large, multigenerational pedigrees (Bourgain et al.
2003). Here, we defined “cases” as individuals with bron-
chial hyperresponsiveness (BHR [MIM 600807]) (np
) and “controls” as individuals with a negative history156
of asthma symptoms and without BHR ( ). Wenp 434
note that all of the affected individuals in the Chicago
families and trios also had BHR (table 1). Only 3 SNPs
in HLA-G (of 21 SNPs genotyped) showed evidence of
association with BHR in the Hutterites ( ) in whomP ! .05
the 964G allele was associated, similar to the results in
the Chicago families.
The 200 Dutch families were ascertained through a
parent in whom asthma was diagnosed ∼30 years ago
(Panhuysen et al. 1995). Therefore, we first examined the
prevalence of BHR and atopy (MIM 147050) in the des-
cendents of each proband. The prevalence of atopy dif-
fered significantly by genotype at HLA-G964 (60% of
AA children, 49% of AG children, and 41% of GG chil-
dren were atopic; ); there was no associationPp .006
with BHR (table 2). However, because of the method of
ascertainment used in the Dutch families, because HLA-
G is an important immunomodulatory molecule during
pregnancy (Hunt et al. 2000; Le Bouteiller et al. 2003),
and because maternal asthma is a significant risk factor
for asthma (Martinez 1997), we next analyzed these data
stratified by mothers’ and fathers’ affection status (BHR
or BHR). The964A allele was overtransmitted to chil-
dren with BHR if the mother was unaffected (57 TR:27
NT; ), whereas the964G allele was overtrans-Pp .004
mitted to children with BHR if the mother was affected
(61 TR:45 NT; ). The differences in transmissionPp .15
patterns of alleles to children with BHR from mothers
with and without BHR was highly significant (Pp
). Similar analyses stratified by father’s asthma.0008
status did not show as significant a trend. Furthermore,
the prevalences of BHR are not different if maternal status
is ignored, but the prevalence of BHR among children
with the GG genotype is significantly influenced by ma-
ternal status (table 2). Among children whose mothers
have BHR, 56% of GG children have BHR; among chil-
dren of mothers without BHR, 26% of GG children have
BHR ( ). No such relationship was observed forPp .001
AA or AG children. Thus, in the Dutch families, GG
children are less likely to be atopic but are more likely to
have BHR if their mother also has BHR. None of the
other five markers typed in the Dutch families showed
associations with either BHR or atopy (table A3 [online
only]).
To further examine interactions between mother’s af-
fection status and child’s genotype, we reexamined the
Chicago families, stratifying the sample by maternal
BHR status (table 3). Genotype distributions in the chil-
dren with asthma differed by mother’s BHR status for
the nine polymorphisms in the HLA-G gene (data not
shown), with three being significant at . SimilarP ! .01
to the Dutch families, the 964GG genotype was as-
sociated with asthma among children of mothers with
a positive BHR affection status, whereas the 964AA
genotype was associated with asthma among children of
mothers with a negative affection status. Other variants
in HLA-G that were not genotyped in the Dutch families
showed more striking differences, suggesting that vari-
ation in the gene in addition to the promoter region may
contribute to risk. A similar trend was observed in the
Hutterites: the frequency of the 964G allele among
children with BHR whose mothers also had BHR was
higher (0.69) than among children with BHR whose
mothers did not have BHR (0.60), although this differ-
ence was not significant ( ).Pp .16
Thus, in the Chicago families and trios and in the Hut-
terite and Dutch families, variants in the HLA-G gene
were associated with asthma or BHR. Although no other
variation that we examined in this region showed asso-
ciations in all four populations, we cannot exclude the
possibility that unidentified variation in HLA-G or in
other genes in block 2 also contributes to susceptibility.
Furthermore, because we observed different alleles and
haplotypes associated in the different populations and
also when stratified by maternal affection status, suscep-
tibility at this locus is complex, influenced by maternal
factors, and associated with multiple related phenotypes.
HLA-G is a novel HLA gene that has limited poly-
morphisms in the coding region and a restricted tissue
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Table 3
Number of Children with Asthma in the Chicago Families,





HLA-G 964 HLA-G 1489
GG AG AA CC CT TT
BHR 12 17 4 18 15 0
BHR 9 19 18 9 30 12
NOTE.—The genotype distribution in the children differs
by mother’s affection status. The 964GG genotype is more
common among children with asthma whose mothers have
BHR, whereas the964AA genotype is more common among
children with asthma whose mothers do not have BHR, al-
though these differences do not reach statistical significance.
Genotype differences are more striking for HLA-G 1489 (dif-
ference between children with asthma of BHR and BHR
mothers, ), the same SNP that explained the evidencePp .009
of linkage.
distribution (Ober and Aldrich 1997). This gene is the
most highly expressed HLA gene in placental cells at the
maternal-fetal interface, where it plays important im-
munoregulatory roles, including the inhibition of mater-
nal NK and T cells and the promotion maternal tolerance
of the allogeneic fetus (Hunt et al. 2000; Le Bouteiller et
al. 2003). Recently, it has been demonstrated that HLA-
G is expressed in adult macrophages, dendritic cells, and
myoblasts in response to inflammation (Yang et al. 1996;
Khosrotehrani et al. 2001; Wiendl et al. 2003), in intes-
tinal biopsies in patients with Crohn disease (Torres et al.
2004), and in malignant and nonmalignant lung diseases
(Pangault et al. 2002). Furthermore, in biopsied myocar-
dial cells from transplanted hearts, expression of HLA-G
is correlated with prolonged graft survival and trans-
plantation success (Rouas-Freiss et al. 2003). In this con-
text, HLA-G is thought to inhibit Th1-mediated inflam-
mation, perhaps in a concentration-dependent manner
(Kapasi et al. 2000). The association of HLA-G variants
with asthma is particularly intriguing, because asthma,
like pregnancy, is characterized by a predominance of Th2
cytokines (Lin et al. 1993). Furthermore, the interaction
between maternal phenotype and the HLA-G genotype
in children in the Dutch and Chicago families is notable,
given the important role that this gene plays in pregnancy
and the fact that maternal asthma is a well-established
risk factor for asthma (Martinez 1997).
To evaluate whether the HLA-G gene could contribute
toward the immunologic milieu in the asthmatic lung,
we studied the expression pattern of HLA-G in lung
tissues from two individuals with asthma, one individual
without asthma, and one individual without asthma but
with a history of cigarette smoking. We demonstrated
by immunohistochemistry the expression of HLA-G in
bronchial epithelial cells (fig. 3). Expression in the lung
was limited to the soluble isoform, HLA-G5 (also called
“soluble G1”) (Fujii et al. 1994). Neither the transmem-
brane G1 and G2 isoforms nor the soluble G6 isoform
were identified in these tissues. Thus, expression of HLA-
G in the lung might contribute toward the aberrant im-
munologic response to inhaled allergens in genetically
susceptible individuals.
Although the LD pattern in this region makes it im-
possible to rule out the possibility that variation in other
genes in block 2 contributes to susceptibility, several lines
of evidence suggest that HLA-G is an asthma suscepti-
bility gene. First, a SNP in HLA-G accounted for nearly
all the linkage in this region. For other variation to be
causal, it would have to be in nearly perfect LD with and
at a similar frequency to the HLA-G 1489C/T SNP (Sun
et al. 2002) and not in LD with the other SNPs tested.
Moreover, if the effect size of our initial linkage signal
was biased upwards because of chance sharing in the
families (Sun et al. 2002), then HLA-G may be the sole
asthma susceptibility gene in this region. Even if the signal
was not biased, additional variation in HLA-G that we
did not sample could also contribute to risk. Second,
among the variants that were surveyed across the linked
region, only SNPs in HLA-G were associated with asthma
or BHR in four different populations, which were ascer-
tained using different strategies. Third, we demonstrated
by immunohistochemistry that the soluble HLA-G iso-
form, G5, was highly expressed in bronchial epithelial
cells in asthmatic lungs. The presence of soluble HLA-
G protein in bronchial epithelial cells indicates that it
could participate in a local inflammatory response to
airborne allergens or other agents. On the basis of these
combined data, we propose that HLA-G is an asthma
susceptibility gene on chromosome 6p21. The differ-
ential association of alleles (or haplotypes) with child-
hood disease on the basis of maternal affection status is
intriguing. Although the contribution of prenatal events
to metabolic diseases such as diabetes and obesity is well
established (Osmond and Barker 2000), the fetal origins
of immune-mediated diseases have received less atten-
tion (Jones et al. 2000; Adams and Nelson 2004). None-
theless, the programming of the fetal immune system
likely begins in utero, and our data suggest that the
maternal immunologic milieu (captured in this study by
the mother’s disease status) may influence the child’s
subsequent response to inhaled allergens in a genotype-
specific manner. One potential mechanism is through
differential methylation, which has been previously im-
plicated in regulating the expression levels of HLA-G
(Onno et al. 1997; Moreau et al. 2003; Ober et al. 2003),
a hypothesis that we are currently investigating.
Finally, many other inflammatory diseases—such as
multiple sclerosis (GAMES and Transatlantic Multiple
Sclerosis Genetics Cooperative 2003), psoriasis (Zhang et
al. 2002b), atopic dermatitis (Soderhall et al. 2001), in-
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Figure 3 A, Control using an irrelevant IgG antibody. B–F, Sections labeled with the anti-HLA-G5 antibody. Epithelial cell labeling may
be increased in basal epithelial cells immediately above the basement membrane (arrows in panels B, C, and E) but also may label columnar
cells (arrowheads in panel B). In areas of damage and focal denudation (D), labeling may be found in remaining epithelial cells. Labeling is
also seen in mucosal and submucosal gland cells (F) in the airway, which are of epithelial origin. Panels A and E are from individuals without
asthma; panel C is from an individual without asthma but with a 30-year smoking history; panels B, D, and F are from individuals with asthma.
mAB 1-2C3 detects soluble HLA-G5 in human bronchial epithelial cells. Human donor lungs that could not be used for transplantation were
obtained under an institutional review board–approved protocol from the Regional Organ Bank of Illinois. Diagnoses were extracted from
medical records. Bronchi were dissected and frozen in OCT. Five-micron sections were stained for antibodies against HLA-G1, HLA-G2, HLA-
G5, and HLA-G6 isoforms, as described elsewhere (Morales et al. 2003). Original magnification was #400 for all images. Antibodies specific
for HLA-G1, HLA-G2, and HLA-G6 were negative in lung sections from patients with asthma as well as those without asthma (not shown).
flammatory bowel disease (Mathew and Lewis 2004), and
schizophrenia (Wright et al. 2001)—have been linked to
the HLA region. To date, all of the variation underlying
these linkages has not been identified. It is tempting to
speculate that variation in the HLA-G gene may contrib-
ute to susceptibility to a wide range of inflammatory dis-
eases, including asthma. Thus, this gene that likely evolved
to promote tolerance in pregnancy may contribute to risk
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for many common diseases, suggesting that novel thera-
peutic strategies could have broad relevance to these im-
mune-mediated diseases.
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